Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Can Fite Biofarma Ltd has a consensus price target of $14 based on the ratings of 2 analysts. The high is $18 issued by HC Wainwright & Co. on May 9, 2024. The low is $10 issued by EF Hutton on August 30, 2024. The 3 most-recent analyst ratings were released by EF Hutton, EF Hutton, and HC Wainwright & Co. on August 30, 2024, July 17, 2024, and May 9, 2024, respectively. With an average price target of $12.67 between EF Hutton, EF Hutton, and HC Wainwright & Co., there's an implied 527.06% upside for Can Fite Biofarma Ltd from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Can Fite Biofarma (AMEX:CANF) was reported by EF Hutton on August 30, 2024. The analyst firm set a price target for $10.00 expecting CANF to rise to within 12 months (a possible 410.20% upside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for Can Fite Biofarma (AMEX:CANF) was provided by EF Hutton, and Can Fite Biofarma maintained their buy rating.
There is no last upgrade for Can Fite Biofarma
There is no last downgrade for Can Fite Biofarma.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Can Fite Biofarma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Can Fite Biofarma was filed on August 30, 2024 so you should expect the next rating to be made available sometime around August 30, 2025.
While ratings are subjective and will change, the latest Can Fite Biofarma (CANF) rating was a maintained with a price target of $10.00 to $10.00. The current price Can Fite Biofarma (CANF) is trading at is $1.96, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.